Hamilton, MolGen and EWC Diagnostics are joining forces to scale up corona testing capacity in the Netherlands

Hamilton, MolGen and EWC Diagnostics are joining forces to increase testing capacity for the COVID-19 virus. According to the three companies, they offer an innovative total solution from patient sample to test result.

Under the partnership, Hamilton will supply the automated RNA extraction and PCR setup. MolGen will supply the RNA extraction chemistry and the (plastic) consumables used in the laboratory process. EWC Diagnostics will supply the CE-IVD marked corona PCR test kits (Pathofinder) as well as the real-time PCR equipment (Bio-Rad) used for the analysis of SARS-CoV-2. MolGen and EWC Diagnostics are jointly responsible for arranging the daily logistics to various laboratories.

These laboratories, spread throughout the Netherlands, have signed up to receive fifteen total test solutions offered by the consortium. By purchasing and producing almost exclusively in the Netherlands, the consortium says it can guarantee the continuous flow of materials.

Since the outbreak of the COVID-19 pandemic in Europe, the demand for corona detection tests has increased significantly. In order to increase testing capacity, the Dutch government, through the Ministry of Health, Welfare and Sport, invited commercial organisations to respond to a tender issued this summer.